Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Submitting Your Manuscript
Brain Connectivity is an international neuroscience journal dedicated to the publication of original research, communications, and scientific reviews concerned with all aspects of anatomical, functional, and causal connections between distinct units within the central nervous system. The journal will consider studies in both human and animal models.
Brain Connectivity is an investigational journal, and research reports are strongly recommended to contain experimental data. Three article categories will be included: original articles, communications, and review articles. Several sub-categories under original articles and communications will be considered, including reports of original experimental data, methodological studies, novel data analysis schemes, theoretical data modeling, and descriptions of changes in brain connectivity in health and disease. Reports of original investigations in the areas of neuroscience, neurology, physics, biophysics, computer science, neuroinformatics, mathematics, chemistry, biochemistry, physiology, developmental biology, genetics, molecular biology, psychiatry, pharmacology, anesthesiology, cell biology, and brain anatomy relevant to the field of brain connectivity will be accepted.
Articles describing the underlying mechanisms and structure behind brain connections will be given priority. Emphasis will be placed on the following experimental techniques:
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET)
- Magnetoencephalography (MEG)
- Single photon emission computed tomography (SPECT)
- Electroencephalography (EEG) along with other imaging modalities
- Other new and evolving methods as applied to brain connectivity analysis
- Submission of multimodal examinations and integrations is encouraged
The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Brain Connectivity before logging in with an ORCID identifier.
Manuscript Submission Site
Create an Account in ScholarOne
If you do not already have an account in ScholarOne for Brain Connectivity, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.
Check the Journal’s PEER REVIEW POLICIES
Manuscripts that do not conform to the requirements herein may be returned to the submitting author with a request for proper formatting prior to peer review.
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.
All Original submissions containing human subjects must include:
- An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
- Patient Consent statement in the Methods section
- Acknowledgments section (if applicable) after the Conclusion of the manuscript, followed by
- An Author Contribution statement for each listed author, followed by
- An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
- Funding statement(s), even if there is no funding information to declare.
All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
When submitting your manuscript for peer review, be prepared to:
- Enter the full title of the manuscript
- Enter the full names and institutional affiliations of ALL listed authors
- Enter ALL listed authors' institutional email addresses
- Identify the corresponding author
- Enter a running (abbreviated) title of no more than 60 characters (including spaces).
- Enter 3–6 keywords or phrases to assist in the selection of skilled reviewers in the field for the purposes of peer review.
- Provide a structured abstract of no more than 250 words
- Include an Impact Statement of 100 words or less describing the importance of the presented research and its potential effect on the field. The placement of this text must be included within the main text file, immediately following the abstract.
- Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
- Confirm that the material has not been published or submitted for publication elsewhere.
All submissions should be accompanied by a cover letter. Authors may convey any relevant information they wish to the Editor, but the cover letter must also assert the following:
- Each author listed on the submission contributed significantly to the work;
- The author listing is complete;
- No fraudulent or manipulated data were used;
- All reported data and results are authentic and valid;
- No content of the submission has been plagiarized.
Create an Effective Title
- Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
- Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
- Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
- Avoid the use of specific locations in the title
- Do not use proprietary/trademarked names in the title
- Do not use acronyms in the title unless they are universally recognized and accepted
- NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).
All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Label each file with the content of the file (i.e.: Text; Tables; FigureLegends; Fig1, etc.)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
- Title page (with full manuscript title, all contributing authors and their institutional affiliations including full postal address, city, state, country name, and email addresses, a short running title, the name, address, telephone and fax numbers, and e-mail address of the corresponding author, and a list of 3-6 keywords)
- Impact Statement
- Main text (do not embed figures or tables)
- Conclusion (as a separate paragraph, not as part of the Discussion section)
- Acknowledgments (if applicable)
- Authorship Confirmation Statement (detailing each author’s contribution to the work)
- Author(s’) Disclosure Statement(s) (actual or potential)
- Funding statement (include funding institution information and grant numbers; if no funding was received, include such a statement)
- References (name/date in text; alphabetical in the reference section. Not in numeric order.)
- Figure legends (all legends in one separate Word file, double-spaced)
- Tables (all tables in one separate Word file; do not include tables as part of the main text file)
- Supplemental files (if applicable; supplied in Word, not as a PDF)
Note: The keywords are search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.
A structured abstract should accompany every original manuscript, review manuscript, or brief communication/report. The abstract should appear on a separate page after the title page and should conform to the following guidelines:
- Do not use proprietary or trade names in the abstract
- The use of the first person should be avoided
- Clearly summarize the results and conclusions of the work
- References are not permitted in the abstract
After the abstract, include a statement of 100 words or less describing the importance of the presented research and its potential effect on the field. The placement of this text must be included within the main text file, immediately following the abstract.
Maximum word count for original articles should not exceed 5,000 words. In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Number and double space all pages. Provide an Impact Statement of 100 words or less describing the importance of the presented research and its potential effect on the field. This text must be included within the main text file and placed immediately following the abstract.
Basic Science submissions must contain a Clinical Trial Registration number.
Brain Connectivity discourages the use of unnecessary acronyms. Overuse of acronyms can cause reduced clarity and therefore the use of acronyms should be limited whenever possible. Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors & Editors or the Council of Biology Editors Style Manual, 10/e. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.
The reference section must be double-spaced, and should be arranged in alphabetical order, and not numbered. More than one reference from the same author(s) in the same year must be identified by the letters "a," "b," "c," etc., placed after the year of publication (i.e.: 2020a), and should be listed chronologically, beginning with the most recent year. If a reference has more than three authors, list the first three, followed by et al.
Within the text, the citation and year of publication should be included in parentheses [e.g.: (Smith, et al., 2019)]. Use journal abbreviations as provided by PubMed/Medline. Any references cited in the text must be included in the reference list, and conversely, all references in the reference section must be cited in the text.
If references to personal communications, unpublished data, or manuscripts in preparation or submitted but not in press are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication, month and year of communication). Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.
Sample style for references:
Smith SD, Fredborg BK, Kornelsen J. Atypical functional connectivity associated with autonomous sensory meridian response: an examination of five resting-state networks. Brain Connect 2019;9:508-518.
Cardoso MJ, Arbel T, Ferrante E, Pennec X, Dalca AV, Parisot S, et al., eds. Graphs in Biomedical Image Analysis, Computational Anatomy and Imaging Genetics. Cham, Switzerland: Springer International Publishing; 2017, p. 3–11.
Chapter in a book:
Arslan S, Rueckert D. Multi-level parcellation of the cerebral cortex using resting-state fMRI. In: Navab N, Hornegger J, Wells WM, Frangi AF, eds. Medical Image Computing and Computer-Assisted Intervention—MICCAI 2015, Part III. Cham, Switzerland: Springer International Publishing; 2015, p. 47–54.
Note: For books and book chapters, include the volume and/or edition numbers when appropriate.
Douaud G, Groves A, Tamnes C, Westlye L, Engvig A, Wavhold K, et al. Mode of variation in brain structure identifies network linking protracted development, early degeneration and vulnerability to disease. In: Proceedings of the Joint Annual Meeting ISMRM-ESMRMB, Milan, Italy, 2014.
Schildkrout B. Functional connectivity: probing the brain’s astounding complexity. 2018. www.psychiatrictimes.com/view/functional-connectivity-probing-brains-astounding-complexity Last accessed June 16, 2020.
Note: Do not include http:// in a website address if www. is present in the URL; include it only if www. is omitted.
Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc., that appear in the figure. Define all relevant information in figures, including figure part labels, footnotes, abbreviations, acronyms, arrows, and levels of magnification in insets. If the illustration is taken from a copyrighted publication, permission must be secured by the authors, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
All tables should be prepared in one separate Word file. Provide a title for each table. Each numbered table should begin on a new page. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. All other types of table footnotes should be designated using superscript letters, not symbols. If the table is taken from a copyrighted publication, permission must be secured by the authors, appropriate credit must be given in the table legend, and a corresponding reference must appear in the reference section.
The depiction of data presented in Brain Connectivity is of the utmost importance to our readers.
- Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
- Figures should not be embedded within the manuscript file.
- Cite figures consecutively in text within parentheses.
- A legend should be supplied for each figure and all legends numbered consecutively.
- Images should not show the name of a patient or a manufacturer.
- Do not include any illustrations as part of your text file.
Chemical Formulae and Mathematical Equations
Wherever possible, write mathematical equations and chemical formulae on a single line. Please submit complex chemical structures as figures. Number equations sequentially in Arabic numerals at the right margin.
Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.
To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.” All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.
Letters to the Editor
Brain Connectivity will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.
Journal Policies on:
Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Archiving and Preservation
For questions regarding manuscript submissions, contact our Author Services Division.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.